Colin Birkenbihl
I am dedicated to solving biomedical challenges and driving innovation in precision medicine utilizing my knowledge of artificial intelligence, machine learning and statistics.
Currently, I am affiliated with the Massachusetts General Hospital and Harvard Medical School in Boston, MA. As part of the Data & Informatics team, I spearhead the AI-driven analysis of patient-level data collected during the Harvard Aging Brain Study.
Research Interests
- Artificial Intelligence
- Machine learning
- Health
- Precision medicine
- AI-improved clinical trial design
- Generative modeling and synthetic data
- Time-series analysis
For posts about my first and last author publications please click here. A list of all the publications I contributed to can be found on my Google Scholar.
Education
- PhD in Computational Life Sciences (completed, awaiting conferral)
- M.Sc. in Life Science Informatics
- B.Sc. in Biology specializing in bioinformatics
Experience in international, collaborative research
- Led a work package on time-series analysis in a Horizon2020 project: TVB-Cloud
- Contributed to the IMI-funded EPAD and AETIONOMY projects
- Contributed to the planning and writing of grant proposals
- Negotiated, conceived, and concluded projects with partners from academia and industry
Teaching and supervision
- Supervised bachelor, master, and PhD students (List)
- Worked as a lecturer at University Bonn:
- Co-tought and graded a seminar about 'Advanced AI methods in the life sciences'
- Gave lectures on
- 'AI and data science': Statistics intro; methods from linear regression to advanced neural networks
- 'biological data bases': Overview on resources available
- 'data management': SQL basics, relational databases, working with clinical data
Editorial service
- Since Jan. 2022 member of the editorial board of the EPMA Journal of predictive, preventive, and personalized medicine
- Served as an associate editor for the Journal of Alzheimer's Disease from 01.2020 to 01.2021
Consulting
- Consultant for AI in Life Sciences for companies such as SambaNova